Our Pipeline
Last updated, April 2021.
Molecule /
Project
|
Indication
|
Expected Launch
|
Preclinical Phase | Phase I | Phase II | Phase III | Under Registration | Geography |
---|---|---|---|---|---|---|---|---|
Tirbanibulin | Actinic Keratosis |
2021
|
|
|||||
MC2-01 | Psoriasis |
2021
|
|
|||||
Lebrikizumab | Atopic dermatitis |
2023
|
|
|||||
Sarecycline | Acne |
2023
|
|
Programs in Research & Preclinical